Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the supplemental Biologics License Application (sBLA) for IMAAVY® ...
Retinopathy of prematurity (ROP) is a major cause of vision impairment in preterm infants, particularly those born weighing ≤1,250 g. Anemia is commonly observed in these infants, with nearly 90% of ...
Anemia in babies may manifest as pale skin, irritability, and a fast heart rate. Sometimes, mild to moderate anemia may not produce symptoms, but severe anemia can have very serious consequences. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results